Top Markets
#1 Black Phoenix Black Phoenix +860.29%
#2 QuantixAI QuantixAI +102.63%
#3 MetaDAO MetaDAO +26.72%
#4 Pons Pons +23.08%
#5 LayerZero LayerZero +20.52%
#6 Ontology Gas Ontology Gas +19.80%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +19.11%
#8 Bedrock Bedrock +18.57%
#9 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.04%
#10 SPX6900 SPX6900 +15.41%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Classificação em ações #2339
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Preço da ação
$43.48
Valor de mercado
$8.97B
Variação (1 dia)
0.37%
Variação (1 ano)
192.01%
País
US
Negociar Immunovant, Inc. (IMVT)

Categoria

Healthcare
Histórico de preços das ações de Immunovant, Inc. (IMVT)
Preço de fecho mais alto: $42.53 em 2026-08-01

Preço de fecho mais baixo: $9.88 em 2019-06-01
Histórico de preços das ações da Immunovant, Inc. de 2019 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.95 42.42%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.63%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $157.63 521.81%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH